Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Levodopa treatment in Parkinson's disease: earlier or later?

Literature DB >> 31656768

Levodopa treatment in Parkinson's disease: earlier or later?

Federico Paolini Paoletti¹, Nicola Tambasco¹, Lucilla Parnetti¹.

Abstract

Entities: Chemical Disease

Year: 2019 PMID： 31656768 PMCID： PMC6789370 DOI： 10.21037/atm.2019.07.36

Source DB: PubMed Journal: Ann Transl Med ISSN： 2305-5839

× No keyword cloud information.

15 in total

Review 1. Levodopa for the treatment of Parkinson's disease.

Authors: Peter A Lewitt
Journal: N Engl J Med Date: 2008-12-04 Impact factor: 91.245

2. Levodopa toxicity and Parkinson disease: still a need for equipoise.

Authors: C Warren Olanow; Jose A Obeso
Journal: Neurology Date: 2011-09-14 Impact factor: 9.910

3. Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.

Authors: Constant V M Verschuur; Sven R Suwijn; Judith A Boel; Bart Post; Bas R Bloem; Johannes J van Hilten; Teus van Laar; Gerrit Tissingh; Alexander G Munts; Guenther Deuschl; Anthony E Lang; Marcel G W Dijkgraaf; Rob J de Haan; Rob M A de Bie
Journal: N Engl J Med Date: 2019-01-24 Impact factor: 91.245

4. Levodopa and the progression of Parkinson's disease.

Authors: Stanley Fahn; David Oakes; Ira Shoulson; Karl Kieburtz; Alice Rudolph; Anthony Lang; C Warren Olanow; Caroline Tanner; Kenneth Marek
Journal: N Engl J Med Date: 2004-12-09 Impact factor: 91.245

Review 5. Levodopa: A new look at an old friend.

Authors: C Warren Olanow; Fabrizio Stocchi
Journal: Mov Disord Date: 2017-11-27 Impact factor: 10.338

6. Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions.

Authors: K P Datla; S B Blunt; D T Dexter
Journal: Mov Disord Date: 2001-05 Impact factor: 10.338

7. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.

Authors: Mariese A Hely; John G L Morris; Wayne G J Reid; Robert Trafficante
Journal: Mov Disord Date: 2005-02 Impact factor: 10.338

8. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

Authors:
Journal: JAMA Date: 2000-10-18 Impact factor: 56.272

Review 9. Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification.

Authors: Javier Blesa; Inés Trigo-Damas; Michele Dileone; Natalia Lopez-Gonzalez Del Rey; Ledia F Hernandez; José A Obeso
Journal: Exp Neurol Date: 2017-10-04 Impact factor: 5.330

10. Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-study.

Authors: Constant V M Verschuur; S R Suwijn; B Post; M Dijkgraaf; B R Bloem; J J van Hilten; T van Laar; G Tissingh; G Deuschl; A E Lang; R J de Haan; R M A de Bie
Journal: BMC Neurol Date: 2015-11-19 Impact factor: 2.474

3 in total